The New Hit Depression Treatment? A Ketamine-Derived Nasal Spray
The Journal.
00:00
Spravato: A Breakthrough in Depression Treatment
This chapter explores the FDA approval of Spravato, the first antidepressant to receive breakthrough designation, and its implications for the future of psychiatric treatment. It includes a personal story of recovery through Spravato and highlights the ongoing exploration of psychedelics in mental health therapies.
Transcript
Play full episode
